RT @bhrenton: New study of vaccine efficacy against hospitalization in adults in 187 hospitals in 9 states: The efficacy of 2 doses of mRNA…
Immunocompromised people should get all recommended #COVID19 vaccine doses, including primary and booster doses, consistent with CDC recommendations. More @CDCMMWR: https://t.co/3eY9oFoTHL.
Effectiveness of 2-Dose Vaccination with mRNA COVID-19 Vaccines https://t.co/tCXuBlEWEX via @CDCgov
RT @bhrenton: New study of vaccine efficacy against hospitalization in adults in 187 hospitals in 9 states: The efficacy of 2 doses of mRNA…
Effectiveness of 2-Dose Vaccination with mRNA COVID-19 Vaccines Against COVID-19–Associated Hospitalizations Among Immunocompromised Adults — Nine States, January–September 2021 https://t.co/s4tCBi5z6G via @CDCgov
RT @bhrenton: New study of vaccine efficacy against hospitalization in adults in 187 hospitals in 9 states: The efficacy of 2 doses of mRNA…
RT @Laurie_Garrett: 2/(cont) disease in immunocompetent people, but - 2-dose mRNA vax only 77% effective in preventing acute illness in imm…
RT @Laurie_Garrett: 2/(cont) disease in immunocompetent people, but - 2-dose mRNA vax only 77% effective in preventing acute illness in imm…
RT @bhrenton: New study of vaccine efficacy against hospitalization in adults in 187 hospitals in 9 states: The efficacy of 2 doses of mRNA…
RT @Laurie_Garrett: 2/(cont) disease in immunocompetent people, but - 2-dose mRNA vax only 77% effective in preventing acute illness in imm…
RT @bhrenton: New study of vaccine efficacy against hospitalization in adults in 187 hospitals in 9 states: The efficacy of 2 doses of mRNA…
New study of vaccine efficacy against hospitalization in adults in 187 hospitals in 9 states: The efficacy of 2 doses of mRNA vaccine was 77% in immunocompromised adults and 90% in immunocompetent adults. These data support recommendations for a 3rd dose.
#COVID19 vaccines protect against hospitalization caused by COVID-19; however, there is some reduced protection among immunocompromised people. More in @CDCMMWR: https://t.co/3eY9oFoTHL. https://t.co/xB9B4wjdzw
RT @Laurie_Garrett: 2/(cont) disease in immunocompetent people, but - 2-dose mRNA vax only 77% effective in preventing acute illness in imm…
Effectiveness of 2-Dose Vaccination with mRNA COVID-19 Vaccines https://t.co/ATHnbxJOsw via @CDCgov
RT @Laurie_Garrett: 2/(cont) disease in immunocompetent people, but - 2-dose mRNA vax only 77% effective in preventing acute illness in imm…
RT @Laurie_Garrett: 2/(cont) disease in immunocompetent people, but - 2-dose mRNA vax only 77% effective in preventing acute illness in imm…
RT @Laurie_Garrett: 2/(cont) disease in immunocompetent people, but - 2-dose mRNA vax only 77% effective in preventing acute illness in imm…
Effectiveness of 2-Dose Vaccination with mRNA COVID-19 Vaccines https://t.co/lEqA4qudp2 via @CDCgov Vaccines are protective in immunocompromised but not as much as in gen population. Supports #ACIP @CDCgov recs for 3 doses + booster in these patients to pr
Effectiveness of 2-Dose Vaccination with mRNA COVID-19 Vaccines https://t.co/006jDNogzI via @CDCgov
Now in @CDCgov's MMWR on lower VE against hospitalization among immunocompromised: "difference persisted irrespective of mRNA vaccine product, age group, and tim-ing of hospitalization relative to SARS-CoV-2 ... variant predominance" https://t.co/v7XOvxp
2/(cont) disease in immunocompetent people, but - 2-dose mRNA vax only 77% effective in preventing acute illness in immunocompromised - supports need for 3rd vax dose for ppl w/cancer, transplants & other immune syst-dampening ailments/treatments. http